BCM
AVNR

BlueCrest Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BlueCrest Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-60,114
Closed -$1.02M – 860
2014
Q4 		$1.02M Buy
+60,114
New +$846K 0.03% 373

BlueCrest Capital Management's AVNR Position: Q1 2015 in Review

BlueCrest Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 60,114 shares — an estimated $1.02M sold.

BlueCrest Capital Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $1.02M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • BlueCrest Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 60,114 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.02M.
  • BlueCrest Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • BlueCrest Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.02M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BlueCrest Capital Management's 13F filing for Q1 2015, filed 15 May 2015.